Treat bacterial infections in many different parts of the body
Manufactured By
Avosia
Availability
In Stock
SIAMOX-CV 228.5, from Avosia Pharma, is a broad-spectrum antibiotic oral suspension formulated with Amoxycillin (200 mg) and Potassium Clavulanate (28.5 mg) per 5 ml. This powerful combination enhances antibacterial activity by pairing Amoxycillin, a penicillin-class antibiotic that inhibits bacterial cell wall synthesis, with Clavulanate, a beta-lactamase inhibitor that protects Amoxycillin from enzymatic degradation. Together, they offer effective treatment for resistant bacterial strains.
Find products similar to Amoxycillin & Potassium Clavulanate Oral Suspension IP, Strength: 228.5 Mg
Interested in this product?Get Latest Price from the seller
About the Company
GST Registration Date
08-05-2023
Legal Status of Firm
Limited Company
Nature of Business
Trader - Retailer
Number of Employees
11 To 25 People
Annual Turnover
1.5 - 5 Cr
IndiaMART Member Since
May 2023
GST
06AAYCA4970C1ZF
Established in the year of 2023, We “Avosia Pharma Private Limited” are Wholesale Trader and Manufacturer of an Pharmaceutical Tablets, etc. We direct all our activities to cater the expectations of customers by providing them excellent quality products as per their gratification. Moreover, we follow moral business policies and crystal pure transparency in all our transactions to keep healthy relations with the customers.
For our accomplishment story, whose continual backing and direction have been useful to us for attaining exponential development in the current market.
